• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚单位抗弓形虫疫苗在实验性感染弓形虫的小鼠中的抗原性和神经保护活性评估。

Assessment of the antigenic and neuroprotective activity of the subunit anti-Toxoplasma vaccine in T. gondii experimentally infected mice.

作者信息

Gatkowska Justyna, Wieczorek Marek, Dziadek Bożena, Dzitko Katarzyna, Dziadek Jarosław, Długońska Henryka

机构信息

Department of Immunoparasitology, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Łódź, Banacha 12/16, Poland.

Department of Neurobiology, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Łódź, Pomorska 141/143, Poland.

出版信息

Vet Parasitol. 2018 Apr 30;254:82-94. doi: 10.1016/j.vetpar.2018.02.043. Epub 2018 Mar 1.

DOI:10.1016/j.vetpar.2018.02.043
PMID:29657017
Abstract

The aim of this study was to evaluate the immunogenic and immunoprotective activities and to determine the neuroprotective capacity of the tetravalent vaccine containing selected recombinant T. gondii antigens (ROP2 + ROP4 + SAG1 + MAG1) administered with safe adjuvants (MPL and alum) using male and female inbred mice. The tested antigenic combination provided partial protection against brain cyst formation, especially in males (reduction in cyst burden by 72%). The decrease in cyst burden was observed for the whole brain as well as for specified brain regions associated with natural defensive behaviors, emotion processing and integration of motor and sensory stimuli. The vaccine triggered a strong, specific immune response, regardless of sex, which was characterized by the antigen-specific in vitro synthesis of cytokines (IL-2, IFN-γ and IL-10) and in vivo production of systemic IgG1 and IgG2a immunoglobulins. Immunization prior to the parasite challenge seemed to influence T. gondii - associated behavioral and neurochemical changes, although the impact of vaccination strongly depended on sex and time post-infection. Interestingly, in the vaccinated and T. gondii infected mice there was a significant delay in the parasite-induced loss of aversion toward cat smell (cats are the definitive hosts of the parasite). The regained attraction toward feline scent in vaccinated males, observed during chronic parasite invasion, correlated with the increase in the dopamine metabolism.

摘要

本研究的目的是评估含选定重组弓形虫抗原(ROP2 + ROP4 + SAG1 + MAG1)与安全佐剂(MPL和明矾)联合使用的四价疫苗对雄性和雌性近交系小鼠的免疫原性和免疫保护活性,并确定其神经保护能力。所测试的抗原组合对脑囊肿形成提供了部分保护,尤其是对雄性小鼠(囊肿负荷减少72%)。在整个大脑以及与自然防御行为、情绪处理以及运动和感觉刺激整合相关的特定脑区均观察到囊肿负荷的降低。该疫苗引发了强烈的特异性免疫反应,且不受性别影响,其特征为细胞因子(IL-2、IFN-γ和IL-10)的抗原特异性体外合成以及全身IgG1和IgG2a免疫球蛋白的体内产生。在寄生虫攻击前进行免疫似乎会影响与弓形虫相关的行为和神经化学变化,尽管疫苗接种的影响在很大程度上取决于性别和感染后的时间。有趣的是,在接种疫苗并感染弓形虫的小鼠中,寄生虫诱导的对猫气味厌恶丧失出现了显著延迟(猫是该寄生虫的终末宿主)。在慢性寄生虫感染期间观察到,接种疫苗的雄性小鼠对猫科动物气味重新产生的吸引力与多巴胺代谢的增加相关。

相似文献

1
Assessment of the antigenic and neuroprotective activity of the subunit anti-Toxoplasma vaccine in T. gondii experimentally infected mice.亚单位抗弓形虫疫苗在实验性感染弓形虫的小鼠中的抗原性和神经保护活性评估。
Vet Parasitol. 2018 Apr 30;254:82-94. doi: 10.1016/j.vetpar.2018.02.043. Epub 2018 Mar 1.
2
Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.评价三种由弓形虫表面和分泌抗原组成的重组多抗原疫苗在实验性弓形虫病小鼠模型中的效果。
Vaccine. 2011 Jan 17;29(4):821-30. doi: 10.1016/j.vaccine.2010.11.002. Epub 2010 Nov 16.
3
Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.弓形虫蛋白酶抑制剂-1(TgPI-1)是一种新型的抗弓形虫病疫苗候选物。
Vaccine. 2008 Sep 15;26(39):5040-5. doi: 10.1016/j.vaccine.2008.07.031. Epub 2008 Aug 21.
4
Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.刚地弓形虫:重组棒状体蛋白2和棒状体蛋白4在小鼠实验性弓形虫病中的免疫原性和保护效力
Exp Parasitol. 2009 Sep;123(1):81-9. doi: 10.1016/j.exppara.2009.06.002. Epub 2009 Jun 7.
5
Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.刚地弓形虫:三种由重组 ROP2、ROP4、GRA4 和 SAG1 蛋白组成的三价抗原鸡尾酒对 BALB/c 小鼠慢性弓形虫病的疫苗潜力。
Exp Parasitol. 2012 May;131(1):133-8. doi: 10.1016/j.exppara.2012.02.026. Epub 2012 Mar 14.
6
Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice.由重组弓形虫TgPI-1、ROP2和GRA4蛋白组成的抗原混合物对C3H小鼠慢性弓形虫病的疫苗潜力。
Exp Parasitol. 2018 Feb;185:62-70. doi: 10.1016/j.exppara.2018.01.006. Epub 2018 Jan 6.
7
Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.表达SAG1、ROP2和GRA2的多抗原DNA疫苗引发的针对刚地弓形虫的免疫反应评估。
Parasitol Int. 2008 Dec;57(4):424-9. doi: 10.1016/j.parint.2008.05.001. Epub 2008 May 16.
8
Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.用编码刚地弓形虫主要表面抗原的复制缺陷型重组腺病毒进行疫苗接种可诱导小鼠产生免疫反应并提供针对感染的保护。
Hum Gene Ther. 2006 Apr;17(4):415-26. doi: 10.1089/hum.2006.17.415.
9
The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.刚地弓形虫毒力相关的 rhoptry 蛋白 5(ROP5)是一种针对小鼠弓形虫病的新型疫苗候选物。
Vaccine. 2013 Sep 23;31(41):4578-84. doi: 10.1016/j.vaccine.2013.07.058. Epub 2013 Aug 5.
10
Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.评估单磷酰脂质A(MPL)佐剂配制的重组致密颗粒抗原GRA2和GRA6对小鼠弓形虫慢性感染的保护作用。
Vaccine. 2007 May 22;25(21):4301-11. doi: 10.1016/j.vaccine.2007.02.057. Epub 2007 Mar 9.

引用本文的文献

1
Toxoplasma gondii vaccine candidates: a concise review.弓形虫疫苗候选物:简要综述。
Ir J Med Sci. 2023 Feb;192(1):231-261. doi: 10.1007/s11845-022-02998-9. Epub 2022 Apr 8.
2
Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Challenge Infection.口服表达ROP4的重组痘苗病毒可诱导对攻毒感染的保护作用。
Vaccines (Basel). 2022 Jan 20;10(2):152. doi: 10.3390/vaccines10020152.
3
Mucosal Administration of Recombinant Baculovirus Displaying ROP4 Confers Protection Against Challenge Infection in Mice.
黏膜给予表达 ROP4 的重组杆状病毒可在小鼠中诱导针对 挑战感染的保护作用。
Front Cell Infect Microbiol. 2021 Sep 29;11:735191. doi: 10.3389/fcimb.2021.735191. eCollection 2021.
4
Immunization With a DNA Vaccine Encoding the ' s GRA39 Prolongs Survival and Reduce Brain Cyst Formation in a Murine Model.用编码弓形虫GRA39的DNA疫苗进行免疫可延长小鼠模型的生存期并减少脑囊肿形成。
Front Microbiol. 2021 Apr 28;12:630682. doi: 10.3389/fmicb.2021.630682. eCollection 2021.
5
A Carbamoyl Phosphate Synthetase II (CPSII) Deletion Mutant of Induces Partial Protective Immunity in Mice.诱导小鼠产生部分保护性免疫的氨甲酰磷酸合成酶II(CPSII)缺失突变体
Front Microbiol. 2021 Jan 14;11:616688. doi: 10.3389/fmicb.2020.616688. eCollection 2020.
6
The Impact of the Antigenic Composition of Chimeric Proteins on Their Immunoprotective Activity against Chronic Toxoplasmosis in Mice.嵌合蛋白的抗原组成对其抗小鼠慢性弓形虫病免疫保护活性的影响
Vaccines (Basel). 2019 Oct 18;7(4):154. doi: 10.3390/vaccines7040154.